Samedan Ltd Pharmaceutical Publishers


Advanced search

Publications European Pharmaceutical Contractor European Biopharmaceutical Review International Clinical Trials Pharmaceutical Manufacturing and Packing Sourcer Innovations in Pharmaceutical Technology Subscribe Online Conferences White Papers Samedan app Pharmaceutical Directory Industry Events Calendar News and Press Releases Employment Opportunities Advertising with us Contact Us

home > pmps > Summer 2008

PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

Summer 2008

At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. PMPS provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of PMPS.

Text

PDF

Manufacturing

X-Ray systems are becoming increasingly valued by the pharmaceutical industry as an indispensable means of non-destructive testing; Martin Allen of Shaw Inspection Systems takes a closer look

The automated CheckWeighing system for dry powder inhalers supports the quality assurance process, outlines James Aitken of Aitken Scientific

Elisabethann Wright of Hogan & Hartson Brussels consider the European Commision’s attempts to strengthen the legal framework for regulating medical devices in Europe

Tom Roche at FM Global assesses how a single incident in one country can have a disastrous impact on the entire global economy

Drug Delivery

Frances L DeGrazio at West Pharmaceutical Services, Inc, outlines the procedures involved and the importance of thorough testing in the leachables and extractables field

Stephen Grant at ANSYS discusses how computational fluid dynamics (CFD) enable a fast and cost-effective evaluation of new drug delivery systems and formulations

Douglas Custato at Helvoet Pharma outlines the options pharma companies will be presented with when choosing the ideal elastomeric closure

Andy Wallace at Comark Ltd encourages investment in wireless monitoring systems – a key tool for those looking to expand into emerging markets

Formulations, Ingredients and Excipients

Many active pharmaceutical ingredients are unstable and subject to degradation. The role of excipients is therefore being viewed as progressively more important. Nigel A Langley and Karen H Chen at Croda Inc (USA) explain how.

Dr Robert Hardy of Aesica explains to PMPS that exceptional service and a well-balanced business model is key in providing contract services to the outsourcing industry

IT and Logistics

Guido Moosmann of Schreiner MediPharm explores the latest innovative technologies for clinical trial supply management

PACKING, PACKAGING & ANTI-COUNTERFEITING

John Haworth at Ditone Labels looks at how the pharma packaging industry has responded to the needs of the blind community

Nicole Golomb at 3S Simons Security Systems GmbH takes us through the various options available to avoid the counterfeit risk

Low and microdose powder filling in the pharmaceutical industry has traditionally been a challenging process. However, new developments are on the way, as Robin Davies of Isopak Ltd explains

COOL CHAIN

Robert Kayum at Kuehne + Nagel explores today’s climate for temperature-sensitive logistics, and the developments in solutions that can transform the role they play in the pharma industry

Published quarterly in
February, May,
August, and November

News and Press Releases

Bormioli Pharma Reveals at CPHI Frankfurt New Prototypes Focusing on Effective, Patient-Centered Innovation

Parma, 19 October 2022 - Bormioli Pharma, an international leader in the production of pharmaceutical packaging and medical devices, will attend at CPHI in Frankfurt (booth 30B20) showcasing a service-driven, innovative and sustainable product offer and reaffirming its positioning as “one-stop shop” partner for the pharma industry.
More info >>

All releases >>

White Papers

Future-proofing serialization solutions: the importance of strong level 3 capabilities

Adents

The complexities surrounding product serialization for pharmaceutical and medical device companies are immense. While current serialization requirements are limited to marking the unit of sale with a unique data carrier, by 2023 the process will require a product to be traceable through the entirety of its journey - from the individual package through the carton/pallet to its final point of distribution. In the United States, the Healthcare Distribution Management Association (HDMA) is suggesting that pharmaceutical companies begin to support this level of serialization, called aggregation, now. Around the world – in Europe and Asia in particular – disparate track and trace practices are incrementally moving toward a global standard that will, undoubtedly, be more stringent than today’s differing benchmarks. How can companies manage this transformation with the greatest degree of success while also minimizing business disruption? The key to creating an optimal implementation strategy is to select a serialization solution that has strong capabilities at all levels of technology. It’s also important to choose a solution that enables multi-phase implementation
More info >>

All white papers >>